While theyre fundamentally similar medications, they differ slightly in their mechanism of action: Wegovy (semaglutide) is a GLP-1 agonist Zepbound (tirzepatide) is a dual agonist: GLP-1 + a glucose-dependent insulinotropic polypeptide (GIP) Both semaglutide and tirzepatide affect the hypothalamus and the hedonic eating centers, the brains center of appetite and cravings
Recently, the results of a landmark randomized controlled trial showed treatment with tirzepatide (15 mg subcutaneous/week), a dual GLP-1R/GIP receptor (GIPR) agonist, caused an 18% placebo-subtracted weight loss (21% total weight loss) at 72 weeks in people with obesity (6)
Clinical trial data is missing
After PSM, our study identified significant differences in transaminase levels, recurrence rates, and mortality after adjuvant chemotherapy between breast cancer patients between GSH group and Non-GSH group, indicating that GSH intake may have adverse effects on chemotherapy outcomes
Tato neesenciln aminokyselina rovn pat i mezi oblben nootropika, co jsou obecn ltky uvan za elem zlepen koncentrace a psychickho vkonu
Purchasing extra doses before departure is a practical strategy for lengthy trips
